Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
68.50
+1.08 (1.60%)
At close: Mar 27, 2024, 4:00 PM
69.86
+1.36 (1.99%)
After-hours: Mar 27, 2024, 7:13 PM EDT

Vaxcyte Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
397.45834.6668.99386.258.9866.09
Short-Term Investments
682.7896.72176.99000
Cash & Cash Equivalents
1,080931.38245.97386.258.9866.09
Cash Growth
15.98%278.65%-36.31%554.84%-10.76%-
Other Current Assets
15.7311.1810.382.82.750.58
Total Current Assets
1,096942.56256.3538961.7266.67
Property, Plant & Equipment
110.6231.6535.913.273.393.41
Long-Term Investments
163.7827.4227.99000
Other Long-Term Assets
37.564.564.090.550.580.72
Total Long-Term Assets
311.9663.6267.993.823.984.13
Total Assets
1,4081,006324.34392.8365.770.8
Accounts Payable
14.599.86.7629.793.382.83
Current Debt
7.115.915.28000
Other Current Liabilities
123.6424.8216.6817.087.683.88
Total Current Liabilities
145.3440.5328.7246.8611.056.71
Long-Term Debt
22.1112.0311.51000.16
Other Long-Term Liabilities
00.010.10.120.713.85
Total Long-Term Liabilities
22.1112.0411.60.120.714.01
Total Liabilities
167.4552.5740.3246.9811.7610.72
Total Debt
29.2217.9416.78000.16
Debt Growth
62.89%6.90%----
Retained Earnings
-924.39-522.13-298.64-198.56-109.35-59.07
Comprehensive Income
0.18-0.36-0.24000
Shareholders' Equity
1,240953.61284.02345.84-106.37-57.73
Net Cash / Debt
1,051913.44229.19386.258.9865.93
Net Cash / Debt Growth
15.06%298.55%-40.66%554.84%-10.55%-
Net Cash Per Share
10.8214.084.4113.0715.5418.16
Working Capital
950.62902.03227.63342.1450.6759.96
Book Value Per Share
12.7714.705.4711.71-28.03-15.90
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).